Recent work by our group has demonstrated that TGFβ positively controls ovarian cancer proliferation through the control of insulin like growth factor 1 receptor (IGF1R) expression levels in some orthotopic mouse models (PDX) and ovarian cancer cell lines [25]. Here, IGF1R is linked to ovarian carcinoma.